APEN - エルパス （Apollo Endosurgery Inc.） エルパスAPENのチャート
APENの企業情報
| symbol | APEN |
|---|---|
| 会社名 | Apollo Endosurgery Inc （エルパス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical/Dental Instruments |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 Apollo Endosurgery Inc. formerly Lpath Inc. is a medical device company. The Company is focused on less invasive therapies for the treatment of obesity as well as other gastrointestinal disorders. The Company''s device-based therapies are an alternative to invasive surgical procedures. The Company offers products in over 80 countries. The Company''s products include ORBERA LAP-BAND and OverStitch. The Company''s product ORBERA is a gastric balloon. The ORBERA Intragastric Balloon System is a weight loss aid for adults suffering from obesity. The LAP-BAND System is a minimally invasive procedure that offers weight loss. The LAP-BAND System is indicated for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables advanced endoscopic surgery by allowing physicians to place full-thickness sutures through a flexible endoscope. OverStitch offers solutions for defects in both the upper and lower gastrointestinal tract. エルパスは、米国のバイオテクノロジ―企業。｢lipidomic｣ベ―スの治療抗体の発見と開発に焦点を当てたる｡｢ iSONEP｣は､sonepcizumabの眼の製剤。｢ASONEP｣は、癌の様々な腫瘍タイプを治療するために処方されsonepcizumabの全身性製剤、および腎細胞癌を有する患者の治療薬。 Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon. |
| 本社所在地 | 1120 S. Capital of Texas Highway Building 1 Suite #300 Austin TX 78746 USA |
| 代表者氏名 | Richard J. Meelia リチャード・J・ミエリア |
| 代表者役職名 | Chairman of the Board 取締役会会長 |
| 電話番号 | +1 512-279-5100 |
| 設立年月日 | － |
| 市場名 | NASDAQ National Market System |
| ipoyear | ―年 |
| 従業員数 | 213人 |
| url | www.apolloendo.com |
| nasdaq_url | https://www.nasdaq.com/symbol/apen |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -15.77900 |
| 終値（lastsale） | 6.9199 |
| 時価総額（marketcap） | 151399772.4304 |
| 時価総額 | 時価総額（百万ドル） 148.33890 |
| 売上高 | 売上高（百万ドル） 64.21500 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 147.26790 |
| 当期純利益 | 当期純利益（百万ドル） -29.89200 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Apollo Endosurgery Inc revenues decreased less than 1% to $31.5M. Net loss increased 17% to $17.7M. Revenues reflect Endo-bariatric segment increase of 25% to $21.1M Other segment increase of 49% to $543K also reflect Surgical segment decrease of 32% to $9.9M United States segment decrease of 14% to $14.5M. Higher net loss reflects Research and development increase of 32% to $5.6M |
APENのテクニカル分析
APENのニュース
Boston Scientific completes $615M acquisition of Apollo Endosurgery 2023/04/04 16:44:49 Seeking Alpha
Apollo Endosurgery is now part of Boston Scientific (BSX) as the latter''s acquisition of the former is now complete. Read more here.
After Sinking 0.96% During Past Week, Is Apollo Endosurgery Inc. (NASDAQ: APEN) Still A Buy? 2023/02/02 17:00:00 Marketing Sentinel
Apollo Endosurgery Inc. (NASDAQ:APEN)’s traded shares stood at 13.04 million during the latest session, with the company’s beta value hitting 2.32. At the last check today, the stock’s price was $9.94, to imply an increase of 1.17% or $0.11 in intraday trading. The APEN share’s 52-week high remains $10.30, putting it -3.62% down since that … After Sinking 0.96% During Past Week, Is Apollo Endosurgery Inc. (NASDAQ: APEN) Still A Buy? Read More »
Apollo Endosurgery Inc. (APEN) Stock Behavior Isn’t As Predictable As You Think 2023/01/28 14:00:00 Stocks Register
Apollo Endosurgery Inc. (NASDAQ:APEN) concluded the trading at $9.83 on Friday, January 27 with a fall of -0.20% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $9.85 and 5Y monthly beta was reading 2.29 with its price kept floating in the … Apollo Endosurgery Inc. (APEN) Stock Behavior Isn’t As Predictable As You Think Read More »
Analyzing Apollo Endosurgery''s Short Interest 2023/01/04 16:38:43 Benzinga
Apollo Endosurgery''s (NASDAQ: APEN ) short percent of float has fallen 63.08% since its last report. The company recently reported that it has 425 thousand shares sold short , which is 1.2% of all regular shares that are available for trading. Based on its trading volume, it would take traders 0.6 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price … Full story available on Benzinga.com
Stifel Downgrades Apollo Endosurgery to Hold 2023/01/03 21:45:01 Investing.com
https://www.investing.com/news/pro/stifel-downgrades-apollo-endosurgery-to-hold-432SI-2972546
Apollo Endosurgery, Inc. (APEN) Q3 2022 Earnings Call Transcript 2022/11/02 02:18:05 Seeking Alpha
Apollo Endosurgery, Inc. (NASDAQ:NASDAQ:APEN) Q3 2022 Earnings Conference Call November 1, 2022 4:30 PM ET Company Participants Matt Kreps – Investor Relations Chas McKhann – Chief…
Apollo Endosurgery, Inc. 2022 Q3 - Results - Earnings Call Presentation (NASDAQ:APEN) 2022/11/01 21:08:07 Seeking Alpha
The following slide deck was published by Apollo Endosurgery, Inc.
Apollo Endosurgery GAAP EPS of -$0.28 misses by $0.05, revenue of $19.57M beats by $1.42M 2022/11/01 20:54:09 Seeking Alpha
Apollo Endosurgery press release (APEN): Q3 GAAP EPS of -$0.28 misses by $0.05.Revenue of $19.57M (+19.7% Y/Y) beats by $1.42M.The company is raising its FY2022 revenue guidance to…
Apollo Endosurgery, Inc.: Apollo Endosurgery to Report Third Quarter Results on November 1, 2022 2022/10/18 12:08:00 Finanz Nachrichten
AUSTIN, TX / ACCESSWIRE / October 18, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestin…
Endoscopic Sleeve Gastroplasty (ESG) Procedure Featured as a "Top 10" Paper at the IFSO 2022 World Congress in Miami 2022/08/31 11:30:00 Wallstreet:Online
Patients undergoing ESG achieved 24% total body weight loss in a bariatric surgery practice in a community setting.AUSTIN, TX / ACCESSWIRE / August 31, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive …
Apollo Endosurgery, Inc. (APEN) Q3 2022 Earnings Call Transcript 2022/11/02 02:18:05 Seeking Alpha
Apollo Endosurgery, Inc. (NASDAQ:NASDAQ:APEN) Q3 2022 Earnings Conference Call November 1, 2022 4:30 PM ET Company Participants Matt Kreps – Investor Relations Chas McKhann – Chief…
Apollo Endosurgery, Inc. 2022 Q3 - Results - Earnings Call Presentation (NASDAQ:APEN) 2022/11/01 21:08:07 Seeking Alpha
The following slide deck was published by Apollo Endosurgery, Inc.
Apollo Endosurgery GAAP EPS of -$0.28 misses by $0.05, revenue of $19.57M beats by $1.42M 2022/11/01 20:54:09 Seeking Alpha
Apollo Endosurgery press release (APEN): Q3 GAAP EPS of -$0.28 misses by $0.05.Revenue of $19.57M (+19.7% Y/Y) beats by $1.42M.The company is raising its FY2022 revenue guidance to…
Apollo Endosurgery, Inc.: Apollo Endosurgery to Report Third Quarter Results on November 1, 2022 2022/10/18 12:08:00 Finanz Nachrichten
AUSTIN, TX / ACCESSWIRE / October 18, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestin…
Endoscopic Sleeve Gastroplasty (ESG) Procedure Featured as a "Top 10" Paper at the IFSO 2022 World Congress in Miami 2022/08/31 11:30:00 Wallstreet:Online
Patients undergoing ESG achieved 24% total body weight loss in a bariatric surgery practice in a community setting.AUSTIN, TX / ACCESSWIRE / August 31, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive …